Abstract
Iodine-131 labelled Biligram1 has been evaluated as a radiopharmaceutical for dynamic scintiscanning of the liver and biliary tract. In 10 normal subjects there was good visualisation of the liver and gallbladder. In 18 patients 131I Biligram was found to be unsatifactory for differentiating parenchymal liver disease from biliary tract obstruction owing to inability to demonstrate the gallbladder when liver function was more than mildly deranged. Quantitative analyses of blood clearance and hepatic activity curves for 131I Biligram were not clinically helpful. Urinary excretion of 131I Biligram increased with the degree of hepatic dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ansari, A.N., Atkins, M.L., Lambrecht, R.M., Redvanly, C.S., Wolf, A.P.: 123I-Indocyanine Green (123I-ICG) as an agent for dynamic studies of the hepatobiliary system. In: Dynamic studies with radioisotopes in medicine, Vol. I, pp. 111–125. Vienna: International Atomic Energy Agency 1975
Britton, K.E., Suwanik, R., Tuntawiroon, C., Premoydin, M., Reuben, A., Narasimha, K., Myers, M., Wood, T.P., Brown, N.J.G.: Computer-assisted blood background subtraction (CABBS) hepatography with 131I-and 123I-bromosulphthalein (BSP). In: Dynamic studies with radioisotopes in medicine, Vol. I, pp. 157–172. Vienna: International Atomic Energy Agency 1975
Buttermann, G., Wolf, I., Pabst, H.W., Hör, G., Schulze, P.E.: Quantitative analysis of hepatograms using a gamma camera and labelled contrast media. In: Dynamic studies with radioisotopes in medicine, Vol. I, pp. 137–155 Vienna, International Atomic Energy Agency 1975
Goris, M.L.: 123I-Iodobromsulphthalein as a liver and biliary scanning agent. J. Nucl. Med. 14, 820–825 (1973)
Lasser, E. C., Lang, J.H.: Contrast-protein interactions. Invest. Radiol. 5, 446–457 (1970)
Meurman, L.: On the distribution and kinetics of injected 131I-rose-bengal. An experimental study with special reference to the evaluation of liver function. Acta Med. Scand. 167, (Suppl. 354) 1–85 (1960)
Moertel, C.G., Owen, C.A.: Evaluation of the radioisotope (131I tagged) rose-bengal liver function test in non-jaundiced patients. J. Lab. Clin. Med. 52, 902–908 (1958)
Quarfordt, S.H., Hilderman, H.L., Valle, D., Waddell, E.: Compartment analysis of sulfobromophthalein transport in normal patients and patients with hepatic dysfunction. Gastroenterology 60, 246–255 (1971)
Ronai, P.M.: Hepatobiliary radiopharmaceuticals: defining their clinical role will be a galling experience. J. Nucl. Med. 18, 488–490 (1977)
Schering Chemicals Limited. In: Biligram-Biliary contrast medium for intravenous injection and infusion. p. 7. Burgess Hill, Sussex: Schering Chemicals Limited 1973
Winston, M.A., Blahd, W.H.: 131I Rose-Bengal imaging techniques in the differential diagnosis of jaundiced patients. Semin. Nucl. Med. 2, 167–175 (1972)
Wistow, B.W., Subramanian, G., Heertum, R.L., Henderson, R.W., Gagne, G.M., Hall, R.C., McAfee, J.G.: An evaluation of 99mTc-labelled hepatobiliary agents. J. Nucl. Med. 18, 455–461 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blackwell, J.N., Finlayson, N.D.C., McLoughlin, G.P. et al. Iodine 131 labelled ioglycamic acid (Biligram) for scintiscanning in hepatobiliary disorders. Eur J Nucl Med 4, 7–11 (1979). https://doi.org/10.1007/BF00257562
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00257562